☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
pivotal P-II
Daiichi Sankyo and AstraZeneca's Enhertu (trastuzumab deruxtecan) Receives EU's Approval for the HER2 Positive Metastatic Breast C...
January 20, 2021
Load more...
Back to Home